col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


267 Results       Page 1

 [1] 
Wiley: British Journal of Haematology
  original article Date Title Authors   All Authors
1 [GO] 2024―Nov―18 Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients Hayley Colton, Natalie Barratt, Nigel Temperton, Hailey Hornsby, Adrienn Angyal, Irina Grouneva, et al. (+31)
2 [GO] 2024―Sep―27 In the SARS-CoV-2 era, do we need to be afraid of obinutuzumab? Joleen Choy, Katharine L. Lewis
3 [GO] 2024―Sep―16 Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India Chepsy Philip, Sushil Selvarajan, Lingaraj Nayak, Hasmukh Jain, Uday Kulkarni, Prasanna Samuel, et al. (+23)
4 [GO] 2024―Jul―08 COVID-19 vaccination in splenectomized patients with immune thrombocytopenia-Response Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, et al. (+4)
5 [GO] 2024―Jul―08 COVID-19 vaccination in splenectomized patients with immune thrombocytopenia: Correspondence Hinpetch Daungsupawong, Viroj Wiwanitkit
6 [GO] 2024―Jul―04 Shift in emergency department utilization by frequent attendees with sickle cell disease during the COVID-19 pandemic: A multicentre cohort study J. S. Rech, A. Cohen, P. Bartolucci, A. Santin, C. Chantalat Auger, L. Affo, et al. (+4)
7 [GO] 2024―Jun―13 Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy Yeong Jer Lim, Victoria Ward, Anthony Brown, Eloise Phillips, Barbara Kronsteiner, Tom Malone, et al. (+24)
8 [GO] 2024―Apr―18 Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia Xiang Liu, Xinai Gan, Jing Xu, Yutong Wang, Jie Huang, Xu He, et al. (+4)
9 [GO] 2024―Mar―20 COVID-19 disease in patients with chronic neutropenia: The experience from the European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias Michail Spanoudakis, Deniz Yilmaz Karapinar, David Dale, Audrey Anna Bolyard, Emily Tran, Jelena Roganovic, et al. (+14)
10 [GO] 2024―Feb―08 Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID-19 prevention Julia Trepl, Chloé Pasin, Dominik Schneidawind, Nicolas J. Mueller, Markus G. Manz, Andriyana K. Bankova, Irene A. Abela
11 [GO] 2023―Nov―28 Safety and efficacy of SARS-CoV-2 vaccination in patients with immune thrombocytopenia: A two-centre review Sara Stefani, Noora Buti, Alice C. J. Hart, Deena Paul, Naghma Rizvi, Vashti Ragoonanan, et al. (+5)
12 [GO] 2023―Nov―21 Increasing insight in the value of repetitive COVID-19 vaccination in patients with haematological malignancies in the Omicron era Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
13 [GO] 2023―Nov―15 Characteristics and outcomes of COVID-19 in Chinese immune thrombocytopenia patients: A prospective cohort study Yunfei Chen, Jiaying Liu, Shuai Shao, Zhen Song, Yueshen Ma, Yuanyuan Tuo, et al. (+19)
14 [GO] 2023―Nov―15 Sequential cellular and humoral responses after repetitive COVID-19 vaccination in patients treated with anti-CD20 antibodies Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Kenji Sakizono, et al. (+7)
15 [GO] 2023―Oct―27 Indolent lymphoma care delivery and outcomes during the COVID-19 pandemic in Ontario, Canada Inna Y. Gong, Anca Prica, Zharmaine Ante, Andrew Calzavara, Monika K. Krzyzanowska, Simron Singh, et al. (+3)
16 [GO] 2023―Oct―13 Low mortality from COVID-19 infection in patients with B-cell lymphoma after bispecific CD20xCD3 therapy Emil R. Kyvsgaard, Caroline Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten U. Niemann, et al. (+3)
17 [GO] 2023―Oct―12 Prolonged platelet hyperactivity after COVID-19 infection Noriko Nara, Mie Shimizu, Masahiro Yamamoto, Tomoki Nakamizo, Azusa Hayakawa, Ken Johkura
18 [GO] 2023―Oct―05 Prolonged shedding of viable SARS-CoV-2 in immunocompromised patients with haematological malignancies: A prospective study Takaya Ichikawa, Tomokazu Tamura, Mutsumi Takahata, Takashi Ishio, Makoto Ibata, Ikumi Kasahara, et al. (+4)
19 [GO] 2023―Oct―03 Immunogenicity and clinical effectiveness of mRNA vaccine booster against SARS-CoV-2 Omicron in patients with haematological malignancies: A national prospective cohort study Lukas Kevličius, Karolis Šablauskas, Kazimieras Maneikis, Dovilė Juozapaitė, Ugnė Ringelevičiūtė, Vilmantė Vaitekėnaitė, et al. (+11)
20 [GO] 2023―Sep―12 Lymphoplasmacytic lymphoma presenting cold agglutinin syndrome: Clonal expansion of KMT2D and IGHV4-34 mutations after COVID-19 Kiyohito Hayashi, Daisuke Koyama, Yuki Sato, Masahiko Fukatsu, Takayuki Ikezoe
21 [GO] 2023―Sep―06 Repeated COVID-19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL Yandong Shen, Jane A. Freeman, Ian Kerridge, Paul Downe, Kartik Naidu, Juliette Holland, Stephen P. Mulligan
22 [GO] 2023―Aug―24 Impairment of platelet function in both mild and severe COVID-19 patients Mariangela Scavone, Claudia Ghali, Mariagrazia Calogiuri, Matteo Sala, Elena Bossi, Tatiana Mencarini, et al. (+9)
23 [GO] 2023―Aug―23 Transient increase in platelet counts associated with COVID-19 infection during TPO-RA as the second-line treatment in children with ITP Zhifa Wang, Xiaoling Cheng, Nan Wang, Jinxi Meng, Jingyao Ma, Zhenping Chen, Runhui Wu
24 [GO] 2023―Aug―07 Early COVID-19 treatment with Sotrovimab in high-risk Beta-thalassemia: Real-life case-series, state of the art and new perspectives Lorenza Torti
25 [GO] 2023―Jul―31 Benefit of repeated COVID-19 vaccination for patients with B-cell malignancies Ulrike Bacher, Evgenii Shumilov, Thomas Pabst
26 [GO] 2023―Jul―13 Early treatment for COVID-19 in patients with haematological malignancies: Much more than a recommendation! Francesco Passamonti, Alessandra Bandera
27 [GO] 2023―Jul―06 High prevalence of persistent COVID-19-related health anxiety and social restriction in patients with haematological disorders G. Agarwal, S. Varghese, M. Francis, J. Willan
28 [GO] 2023―Jul―05 Humoral and cellular responses to SARS-CoV-2 in patients with B-cell haematological malignancies improve with successive vaccination Christopher L. Pinder, Dylan Jankovic, Thomas A. Fox, Amy Kirkwood, Louise Enfield, Aljawharah Alrubayyi, et al. (+10)
29 [GO] 2023―Jun―24 Response to mRNA SARS-CoV-2 vaccination evaluated by B-cell receptor repertoire after tixagevimab/cilgavimab administration Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Takaji Matsutani, Wataru Hojo, Hironori Sakai, et al. (+13)
30 [GO] 2023―Jun―12 Defective T-cell response to COVID-19 vaccination in acute myeloid leukaemia and myelodysplastic syndromes Justin Loke, Vinit Upasani, Charlotte Gaskell, Sonia Fox, Rachel Fletcher, Catherine Thomas, et al. (+28)
31 [GO] 2023―Jun―08 Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease Hirotomo Nakahara, Narayanaiah Cheedarla, Hans P. Verkerke, Suneethamma Cheedarla, Shang-Chuen Wu, Jeanne E. Hendrickson, et al. (+7)
32 [GO] 2023―Jun―01 Oral anti-viral therapy for early COVID-19 infection in patients with haematological malignancies: A multicentre prospective cohort Carla Minoia, Lucia Diella, Tommasina Perrone, Giacomo Loseto, Carmen Pelligrino, Immacolata Attolico, et al. (+11)
33 [GO] 2023―May―23 The evolution of the COVID -19 pandemic in paediatric patients with sickle cell disease: From Alpha to Omicron Olufunke Y. Martin, Stefanie Margulies, Barbara Speller-Brown, Suvankar Majumdar, Deepika S. Darbari, Andrew D. Campbell
34 [GO] 2023―Mar―21 Burden of COVID-19 disease and vaccine coverages in Apulian splenectomized patients: A retrospective observational study Francesco Paolo Bianchi, Pasquale Stefanizzi, Donato Rizzi, Noemi Signorile, Eustachio Cuscianna, Antonio Daleno, et al. (+2)
35 [GO] 2023―Mar―02 Mortality and burden of post-COVID -19 syndrome have reduced with time across SARS-CoV -2 variants in haematology patients John Willan, Gaurav Agarwal, Nicola Bienz
36 [GO] 2023―Feb―21 Outcome of early treatment of SARS-CoV -2 infection in patients with haematological disorders Malgorzata Mikulska, Diletta Testi, Chiara Russo, Elisa Balletto, Chiara Sepulcri, Linda Bussini, et al. (+21)
37 [GO] 2023―Feb―17 Correction to “Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID -19: The GIMEMA EMATO -0321 study”MarascoV, PiciocchiA, CandoniA, PaganoL, GuidettiA, MustoP, et al. Neutralizing monoclonal antibodies in haematological patients paucisymptomatic for COVID-19: The GIMEMA EMATO-0321 study. Br J Haematol. 2022;199(1):54-60.
38 [GO] 2023―Feb―10 Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine ( R-MIV ) in patients with primary CNS lymphoma including recent COVID -19 pandemic experience Beata Ostrowska, Katarzyna Domanska-Czyz, Joanna Romejko-Jarosinska, Michal Osowiecki, Lukasz Targonski, Lidia Poplawska, et al. (+17)
39 [GO] 2022―Dec―24 Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV -2 and non-SARS-CoV -2 vaccination: 32 Years of passive surveillance data Jeremy W. Jacobs, Garrett S. Booth, Juliana Guarente, Danielle Schlafer, Leon Zheng, Brian D. Adkins
40 [GO] 2022―Dec―21 SARS-CoV-2 infection and vaccination in patients with hairy-cell leukaemia Enrico Tiacci, Alessandro Mancini, Monia Marchetti, Gianna Maria D'Elia, Anna Candoni, Alessandro Morotti, et al. (+19)
41 [GO] 2022―Dec―09 Immune correlates of protection by vaccine against SARS-CoV -2 in patients with chronic lymphocytic leukaemia Daniele Sorcini, Filomena De Falco, Marco Gargaro, Silvia Bozza, Valerio Guarente, Valeria Cardinali, et al. (+18)
42 [GO] 2022―Nov―22 Clinical utility of haematological inflammatory biomarkers in predicting 30-day mortality in hospitalised adult patients with COVID-19 Ahmed Embaby, Mohamed Gaber Hamed, Huda Ebian, Lobna A. El-Korashi, Mohammad Walaa, Eman M. Abd el-Sattar, et al. (+2)
43 [GO] 2022―Nov―16 Antibody response to a third SARS-CoV-2 vaccine dose in recipients of an allogeneic haematopoietic cell transplantation Andriyana K. Bankova, Chloé Pasin, Alice Huang, Caroline Cicin-Sain, Selina Epp, Annette Audige, et al. (+14)
44 [GO] 2022―Nov―10 Safety of coronavirus disease 2019 vaccines in 213 adult patients with sickle cell disease Laure Joseph, Anne Corbasson, Sandra Manceau, Djamal Khimoud, Benoit Meunier, Geoffrey Cheminet, et al. (+4)
45 [GO] 2022―Nov―08 Antibody status following booster vaccination against SARS-CoV -2 virus in patients with haematologic malignancies Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Ayumi Kuzume, et al. (+7)
46 [GO] 2022―Oct―07 Coronavirus disease 2019 ( COVID -19): Focus on peripheral blood cell morphology Gina Zini, Giuseppe d'Onofrio
47 [GO] 2022―Oct―05 Remission of extranodal NK /T-cell lymphoma, nasal type, after SARS-CoV -2 vaccination Mengxiang Chen, Fu Ouyang, Tao Wu, Yunfei Hu, Yan Du, Yunhong Huang
48 [GO] 2022―Sep―21 Clinical outcomes and immune responses to SARS-CoV -2 vaccination in severe aplastic anaemia Roma V. Rajput, Xiaoyang Ma, Kristin L. Boswell, Martin Gaudinski, Ingelise Gordon, Laura Novik, et al. (+21)
49 [GO] 2022―Sep―05 Induction of robust humoral immunity against SARS-CoV -2 after vaccine administration in previously infected haematological cancer patients Cinzia Borgogna, Riccardo Bruna, Gloria Griffante, Licia Martuscelli, Marco De Andrea, Daniela Ferrante, et al. (+12)
50 [GO] 2022―Aug―26 Central venous catheter-related bloodstream infections in patients with haematological malignancies during the SARS-CoV -2 pandemic Enrico Schalk, Timo Schmitt, Jens Panse, Eva Fiegle, Jan-Hendrik Naendrup, Martin Schmidt-Hieber, et al. (+4)
51 [GO] 2022―Aug―10 Impact of severe acute respiratory syndrome coronavirus-2 infection on the outcome of primary central nervous system lymphoma treatment: A study of the International PCNSL Collaborative Group Sara Steffanoni, Teresa Calimeri, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, et al. (+22)
52 [GO] 2022―Jun―03 The impact of COVID-19 on related-donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey Julia Wolf, Julia Lee, Rachel Pearce, Marie Wilson, John A. Snowden, Kim Orchard
53 [GO] 2022―May―17 Anti-severe acute respiratory syndrome coronavirus-2 adenoviral-vector vaccines trigger subclinical antiplatelet autoimmunity and increase of soluble platelet activation markers Eleonora Petito, Elisabetta Colonna, Emanuela Falcinelli, Anna Maria Mezzasoma, Enrica Cesari, Elisa Giglio, et al. (+4)
54 [GO] 2022―May―10 Antibody responses to SARS-CoV -2 vaccination in patients with acute myeloid leukaemia and high risk MDS on active anti-cancer therapies W. Y. Chan, C. Zhu, E. Sanchez, R. Gupta, A. K. Fielding, A. Khwaja, et al. (+2)
55 [GO] 2022―Apr―12 Can B cell-deficient patients rely on COVID-19 vaccine-induced T cell immunity? Tanaya Shree
56 [GO] 2022―Mar―14 Immune response and adverse events after vaccination against SARS-CoV -2 in adult patients with transfusion-dependent thalassaemia Polyxeni Delaporta, Evangelos Terpos, Elena E. Solomou, Sentiljana Gumeni, Evangelia Nitsa, Filia Apostolakou, et al. (+6)
57 [GO] 2022―Mar―09 Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study Masashi Nishikubo, Yoshimitsu Shimomura, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, Kenji Sakizono, et al. (+15)
58 [GO] 2022―Mar―07 Rituximab-treated lymphoma patients develop strong CD8 T-cell responses following COVID-19 vaccination Jon Riise, Saskia Meyer, Isaac Blaas, Adity Chopra, Trung T Tran, Marina Delic-Sarac, et al. (+16)
59 [GO] 2022―Feb―28 Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies Akio Mori, Masahiro Onozawa, Shihori Tsukamoto, Takashi Ishio, Emi Yokoyama, Koh Izumiyama, et al. (+5)
60 [GO] 2022―Feb―17 Depletion of CD38 -positive regulatory T cells by anti-CD38 monoclonal antibodies induces a durable response to SARS-CoV -2 vaccination in patients with plasma cell dyscrasia Toshiki Terao, Takashi Naduka, Daisuke Ikeda, Ami Fukumoto, Yuya Kamura, Ayumi Kuzume, et al. (+6)
61 [GO] 2022―Feb―17 Serological response to SARS-CoV-2 mRNA-LNP vaccine in patients with multiple myeloma: a negative impact of CD38 + Treg? Frédéric Baron, Jo Caers, Stéphanie Humblet-Baron
62 [GO] 2022―Feb―12 The Impact of B-cell Directed Therapy on SARS-CoV-2 Vaccine Efficacy in CLL Chaitra Ujjani, Mazyar Shadman, Ryan C. Lynch, Brian Tu, Philip A. Stevenson, Caitlin Grainger, et al. (+14)
63 [GO] 2022―Feb―02 Association of Rhesus Factor Blood Type with Risk of SARS-CoV-2 Infection and COVID-19 Severity Jeffrey L Anderson, Heidi T. May, Stacey Knight, Tami L Bair, Benjamin D Horne, Kirk U Knowlton
64 [GO] 2022―Jan―25 Platelets modulate CD4 + T Cell function in Covid-19 Through A PD-L1 Dependent Mechanism Ana Paletta, Facundo Di Diego García, Augusto Varese, Fernando Erra Diaz, Julián García, Juan Carlos Cisneros, et al. (+12)
65 [GO] 2022―Jan―25 BNT162b2 mRNA COVID-19 vaccine booster induces seroconversion in patients with B-cell non-Hodgkin lymphoma who failed to respond to two prior vaccine doses Irit Avivi, Efrat Luttwak, Esther Saiag, Tami Halperin, Shira Haberman, Ariel Sarig, et al. (+4)
66 [GO] 2022―Jan―25 Third dose of COVID-19 vaccine restores immune response in patients with haematological malignancies after loss of protective antibody titers O. Šušol, B. Hájková, H. Zelená, R. Hájek
67 [GO] 2022―Jan―22 Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T cell response Karthik Ramasamy, Ross Sadler, Sally Jeans, Paul Weeden, Sherin Varghese, Alison Turner, et al. (+14)
68 [GO] 2022―Jan―14 The impact of COVID-19 vaccination on patients with a history of heparin induced thrombocytopenia U. Faruqi, K. White, N. Murray, J. Cutler, K. Breen
69 [GO] 2022―Jan―14 COVID-19 Vaccine Response in Chronic Lymphocytic Leukaemia is More Than Just Seroconversion Clare Sun
70 [GO] 2022―Jan―14 Response to vaccination against SARS-CoV-2 in 168 patients with Waldenström macroglobulinemia: a French Innovative Leukemia Organization (FILO) study Cécile Tomowiak, Véronique Leblond, Kamel Laribi, Marine Baron, Christian Puppinck, Paulette Gérard, et al. (+7)
71 [GO] 2021―Dec―28 Plasma microparticles of intubated COVID-19 patients cause endothelial cell death, neutrophil adhesion and netosis, in a phosphatidylserine-dependent manner Yohann Garnier, Livia Claude, Patricia Hermand, Evely Sachou, Aurélie Claes, Kassandra Desplan, et al. (+7)
72 [GO] 2021―Dec―28 COVID-19 Vaccine Failure in Chronic Lymphocytic Leukaemia and Monoclonal B-Lymphocytosis; Humoral and Cellular Immunity Yandong Shen, Jane A. Freeman, Juliette Holland, Ann Solterbeck, Kartik Naidu, Asha Soosapilla, et al. (+12)
73 [GO] 2021―Dec―28 Post-COVID-19 syndrome in patients with haematological disorders who have survived infection with severe acute respiratory syndrome coronavirus-2 John Willan, Lidice Hernandez, Harley Katz, Nicola Gray, Nicola Bienz
74 [GO] 2021―Dec―10 Unusual pattern of thrombotic events in young adult non-critically ill patients with COVID-19 may result from an undiagnosed inherited and acquired form of thrombophilia Mahmoud I. Elbadry, Ahmed Tawfeek, Mohammed G. Abdellatif, Eman H. Salama, Ahmed Abudeif, Hany Mahmoud, et al. (+3)
75 [GO] 2021―Dec―07 Efficacy and safety of heterologous booster vaccination with Ad26.COV2.S after BNT162b2 mRNA COVID-19 vaccine in haemato-oncological patients with no antibody response Patrick Reimann, Hanno Ulmer, Beatrix Mutschlechner, Magdalena Benda, Luciano Severgnini, Andreas Volgger, et al. (+10)
76 [GO] 2021―Dec―01 Effectiveness of COVID-19 vaccination in patients after allogeneic haematopoietic cell transplant: how much protection are we getting? Salyka Sengsayadeth, Larisa Broglie, Bipin N. Savani
77 [GO] 2021―Nov―16 A case of severe aplastic anaemia after SARS-CoV-2 vaccination Nicola Cecchi, Juri Alessandro Giannotta, Wilma Barcellini, Bruno Fattizzo
78 [GO] 2021―Nov―12 Adjunctive viral cell culture supports treatment decision-making in patients with secondary humoral immunodeficiency and persistent SARS-CoV-2 infection Scott J. C. Pallett, Rachel Wake, Jonathan Youngs, Cassie Pope, Ngee Keong Tan, Joshua Taylor, et al. (+10)
79 [GO] 2021―Nov―11 Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy Stephen Booth, Helen M. Curley, Csilla Varnai, Roland Arnold, Lennard Y. W. Lee, Naomi A. Campton, et al. (+29)
80 [GO] 2021―Oct―29 Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in haematopoietic stem cell transplantation recipients Noga Shem-Tov, Ronit Yerushalmi, Ivetta Danylesko, Vladislav Litachevsky, Itzchak Levy, Liraz Olmer, et al. (+5)
81 [GO] 2021―Oct―28 Is COVID-19 less severe in CML patients than in those with other haematological cancers? Simone Claudiani
82 [GO] 2021―Oct―19 T-cell immune response after mRNA SARS-CoV-2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies Vincenzo Marasco, Cristiana Carniti, Anna Guidetti, Lucia Farina, Martina Magni, Rosalba Miceli, et al. (+9)
83 [GO] 2021―Oct―15 COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report Massimo Breccia, Elisabetta Abruzzese, Vincenzo Accurso, Immacolata Attolico, Sara Barulli, Micaela Bergamaschi, et al. (+43)
84 [GO] 2021―Oct―13 Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J. Chavda, et al. (+16)
85 [GO] 2021―Oct―09 Impact of major bleeding and thrombosis on 180-day survival in patients with severe COVID-19 supported with veno-venous extracorporeal membrane oxygenation in the United Kingdom: a multicentre observational study Deepa J. Arachchillage, Indika Rajakaruna, Ian Scott, Mihaela Gaspar, Zain Odho, Winston Banya, et al. (+11)
86 [GO] 2021―Oct―09 Conflicting impacts of tocilizumab and colchicine in COVID-19-associated coagulop Suhair Abdeen, Rami Abu-Fanne, Khalil Bdeir, Emad Maraga, Mohamed Higazi, Douglas B. Cines, et al. (+2)
87 [GO] 2021―Sep―21 Low seropositivity and suboptimal neutralisation rates in patients fully vaccinated against COVID-19 with B-cell malignancies Thomas A. Fox, Amy A. Kirkwood, Louise Enfield, Maeve O'Reilly, Suzanne Arulogun, Shirley D'Sa, et al. (+14)
88 [GO] 2021―Sep―16 Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, et al. (+9)
89 [GO] 2021―Sep―15 Refusing blood transfusions from COVID-19-vaccinated donors: are we repeating history? Jeremy W. Jacobs, Lorin A. Bibb, Bipin N. Savani, Garrett S. Booth
90 [GO] 2021―Sep―14 The real impact of COVID-19 on an East London Sickle cell population: results of a service-wide survey Rhys Hall, John Meenan, Diana Mihalca, Alvin Katumba, Saket Badle, Dede-Kossi Osakonor, et al. (+6)
91 [GO] 2021―Sep―09 Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study Deepa J. Arachchillage, Indika Rajakaruna, Zain Odho, Christina Crossette-Thambiah, Phillip L. R. Nicolson, Lara N. Roberts, et al. (+24)
92 [GO] 2021―Aug―30 Convalescent plasma and remdesivir for protracted COVID-19 in a patient with chronic lymphocytic leukaemia: a case report of late relapse after rapid initial response Carla Schenker, Cédric Hirzel, Laura N. Walti, Sacha S. Zeerleder, Martin Andres, Alban Ramette, et al. (+4)
93 [GO] 2021―Aug―27 A real-world study of immune thrombocytopenia management during the COVID-19 pandemic in the UK Alexandros Rampotas, Edmund Watson, Kieran Burton, Quentin A. Hill, Sue Pavord
94 [GO] 2021―Aug―04 Serological SARS-CoV-2 antibody response, potential predictive markers and safety of BNT162b2 mRNA COVID-19 vaccine in haematological and oncological patients Magdalena Benda, Beatrix Mutschlechner, Hanno Ulmer, Claudia Grabher, Luciano Severgnini, Andreas Volgger, et al. (+9)
95 [GO] 2021―Aug―02 Monoclonal antibodies for the treatment of COVID-19 in a patient with high-risk acute leukaemia Paul Saultier, Laetitia Ninove, Sarah Szepetowski, Mathilde Veneziano, Sandrine Visentin, Vincent Barlogis, et al. (+5)
96 [GO] 2021―Jul―29 Development of antibody response to SARS-CoV-2 following asymptomatic infection in patients with plasma cell disorders on immunomodulatory therapy Wei Yee Chan, Emilie Sanchez, Selina J. Chavda, Catherine S. Y. Lecat, Louise Ainley, Ke Xu, et al. (+11)
97 [GO] 2021―Jul―27 Haemophagocytosis and atypical vacuolated lymphocytes in bone marrow and blood films after SARS-CoV-2 vaccination Mouna Sassi, Linda Khefacha, Rihem Merzigui, Rim Rakez, Sarra Boukhriss, Mohamed A. Laatiri
98 [GO] 2021―Jul―17 COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies Francesco Passamonti, Alessandra Romano, Marco Salvini, Francesco Merli, Matteo G. Della Porta, Riccardo Bruna, et al. (+48)
99 [GO] 2021―Jul―11 Immature platelets in COVID-19 infection Robert W. Maitta
100 [GO] 2021―Jul―06 Experts’ views on COVID-19 vaccination and the impact of the pandemic on patients with Gaucher disease Uri Hamiel, Alina Kurolap, Ian J. Cohen, Noa Ruhrman-Shahar, Tova Hershkovitz, Claus Niederau, et al. (+5)
101 [GO] 2021―Jun―27 Cold agglutinin disease after COVID-19 vaccine Shaima Al Aoun, Ibraheem Motabi
102 [GO] 2021―Jun―25 Response to correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine Valerio De Stefano, Marcello Candelli, Elena Rossi, Francesco Franceschi
103 [GO] 2021―Jun―16 The clinical course of COVID-19 in pregnant versus non-pregnant women requiring hospitalisation: results from the multicentre UK CA-COVID-19 study Christina Crossette-Thambiah, Pip Nicholson, Indika Rajakaruna, Alexander Langridge, Zara Sayar, Maria Rita Perelta, et al. (+10)
104 [GO] 2021―Jun―16 Immature platelets as a biomarker for disease severity and mortality in COVID-19 patients Daniel Welder, Haekyung Jeon-Slaughter, Bilal Ashraf, Sung-Hee Choi, Weina Chen, Ibrahim Ibrahim, Taha Bat
105 [GO] 2021―Jun―16 Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms Onima Chowdhury, Hannah Bruguier, Garry Mallett, Nikolaos Sousos, Kirsty Crozier, Caroline Allman, et al. (+10)
106 [GO] 2021―Jun―16 Primary Haemophagocytic Lymphohistiocytosis (Chédiak-Higashi Syndrome) triggered by acute SARS-CoV-2 infection in a 6-week-old infant M Lange, T Linden, HL Müller, AM Flasskuehler, H Koester, K Lehmberg, et al. (+4)
107 [GO] 2021―Jun―11 COVID-19 and Immunothrombosis: emerging understanding and clinical management Rebecca J. Shaw, Charlotte Bradbury, Simon T. Abrams, Guozheng Wang, Cheng-Hock Toh
108 [GO] 2021―Jun―11 Immunothrombosis: a COVID-19 concerto George Goshua, Ayesha Butt, Alfred I. Lee
109 [GO] 2021―Jun―11 Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS-CoV-2 vaccine Quentin Scanvion, Marc Lambert, Eric Hachulla, Louis Terriou
110 [GO] 2021―Jun―09 Increased platelet activation in SARS-CoV-2 infected non-hospitalised children and adults, and their household contacts Conor McCafferty, Suelyn Van Den Helm, Natasha Letunica, Chantal Attard, Vasiliki Karlaftis, Tengyi Cai, et al. (+10)
111 [GO] 2021―Jun―08 Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19 Pratik A. Patel, Stacey A. Lapp, Gabrielle Grubbs, Venkata V. Edara, Christina A. Rostad, Claire L. Stokes, et al. (+6)
112 [GO] 2021―Jun―07 Management of a patient with a rare congenital limb malformation syndrome after SARS-CoV-2 vaccine-induced thrombosis and thrombocytopenia (VITT) Sandheeah Ramdeny, Ailidh Lang, Sara Al-Izzi, Alexander Hung, Imran Anwar, Poornima Kumar
113 [GO] 2021―Jun―07 Rectus sheath and retroperitoneal haematomas in patients with Coronavirus 2019 infection Phoebe Hazenberg, Symeon Lechareas, Marcelo Vasquez Rios, Miriam Taegtmeyer, Richard McWilliams, Tina Dutt
114 [GO] 2021―Jun―04 Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemia Patrick Harrington, Katie J. Doores, Deepti Radia, Amy O’Reilly, Ho Pui Jeff Lam, Jeffrey Seow, et al. (+15)
115 [GO] 2021―Jun―02 Exacerbation of immune thrombocytopenia following Covid-19 vaccination David J. Kuter
116 [GO] 2021―May―30 Alpha-defensins: risk factor for thrombosis in COVID-19 infection Suhair Abdeen, Khalil Bdeir, Rami Abu-Fanne, Emad Maraga, Mohamed Higazi, Nigar Khurram, et al. (+7)
117 [GO] 2021―May―30 Antithrombin III deficiency-induced coagulopathy in the context of COVID-19: a case series Andrew J. Gardner, Daniel J. Kirkin, Sancho Rodriguez-Villar, Gonzalo Leoz Abellanas, Alice Tee, Antonio Valentin
118 [GO] 2021―May―26 COVID-19 in patients with paroxysmal nocturnal haemoglobinuria: an Italian multicentre survey Wilma Barcellini, Bruno Fattizzo, Juri A. Giannotta, Luisa Quattrocchi, Semra Aydin, Federica Barone, et al. (+9)
119 [GO] 2021―May―26 Acute events in children with sickle cell disease in Italy during the COVID-19 pandemic: useful lessons learned Vania Munaretto, Vincenzo Voi, Giovanni Palazzi, Lucia Dora Notarangelo, Paola Corti, Valentina Baretta, et al. (+26)
120 [GO] 2021―May―24 Incidence of thrombotic complications in hospitalised and non-hospitalised patients after COVID-19 diagnosis Birgitte Tholin, Waleed Ghanima, Gunnar Einvik, Bernt Aarli, Eivind Brønstad, Ole H. Skjønsberg, Knut Stavem
121 [GO] 2021―May―16 Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19 Gina Sangha, Kunaal Kaushik, Amelia Robinson, Thomas Ainge, Moez Dungarwalla, Arup Chakraborty
122 [GO] 2021―May―16 Limited utility of the HScore in detecting secondary haemophagocytic lymphohistiocytosis in COVID-19: response Henry Wood, Austin G. Kulasekararaj
123 [GO] 2021―May―15 Incidence, characteristics and clinical profile of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with pre-existing primary immune thrombocytopenia (ITP) in Spain María E. Mingot-Castellano, Patricia Alcalde-Mellado, Cristina Pascual-Izquierdo, Gloria Perez Rus, Aida Calo Pérez, María P. Martinez, et al. (+9)
124 [GO] 2021―May―08 Preoperative patient blood management during the SARS-CoV-2 pandemic Katie Hands, Craig Taylor, Alwyn Kotzé, Toby Richards, Shruthi Narayan
125 [GO] 2021―May―02 Immune thrombocytopenic purpura after SARS-CoV-2 vaccine Marcello Candelli, Elena Rossi, Federico Valletta, Valerio De Stefano, Francesco Franceschi
126 [GO] 2021―Apr―30 COVID-19 infection in patients with severe aplastic anaemia Casey Paton, Liza Mathews, Emma M. Groarke, Olga Rios, Jennifer Lotter, Bhavisha A. Patel, Neal S. Young
127 [GO] 2021―Apr―15 Immune thrombocytopenia during the COVID-19 pandemic Eun-Ju Lee, Xinguang Liu, Ming Hou, James B. Bussel
128 [GO] 2021―Mar―25 The psychosocial impact of the COVID-19 pandemic on MGUS, smouldering and active myeloma patients: findings from an international survey Stephen J. Quinn, Lesley A. Anderson, Lynne Lohfeld, Charlene M. McShane
129 [GO] 2021―Mar―15 Evidence of robust memory T-cell responses in patients with chronic myeloproliferative neoplasms following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Patrick Harrington, Claire N. Harrison, Richard Dillon, Deepti H. Radia, Katayoun Rezvani, Kavita Raj, et al. (+8)
130 [GO] 2021―Feb―18 Unusual morphological abnormality of neutrophils in a patient with SARS-CoV-2 infection Praveen Sharma, Shano Naseem, Neelam Varma, Pankaj Malhotra
131 [GO] 2021―Feb―07 COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies Eleonora Calabretta, Jose M. Moraleda, Massimo Iacobelli, Ruben Jara, Israel Vlodavsky, Peter O’Gorman, et al. (+8)
132 [GO] 2021―Feb―03 Convalescent plasma for COVID-19 - encouraging signals of efficacy Arturo Casadevall, Aaron A. R. Tobian
133 [GO] 2021―Feb―01 Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation: a Société Francophone de Greffe de Moelle et de Thérapie cellulaire (SFGM-TC) multicentre cohort study Alienor Xhaard, Constance Xhaard, Maud D’Aveni, Helene Salvator, Marie-Laure Chabi, Ana Berceanu, et al. (+14)
134 [GO] 2021―Jan―25 Paradoxical effect of SARS-CoV-2 infection in patients with immune thrombocytopenia Beatriz de la Cruz-Benito, María I. Rivas-Pollmar, María T. Álvarez Román, Roberto Trelles-Martínez, Monica Martín-Salces, Paula Lázaro-del Campo, et al. (+8)
135 [GO] 2021―Jan―23 Early mortality benefit with COVID-19 convalescent plasma: a matched control study Aarthi G. Shenoy, Aaron Z. Hettinger, Stephen J. Fernandez, Joseph Blumenthal, Valentina Baez
136 [GO] 2021―Jan―21 The NICE COVID-19 rapid guideline on haematopoietic stem cell transplantation: development, implementation and impact Kim Orchard, Fiona L. Dignan, Julia Lee, Rachel Pearce, Monica Desai, Emma McFarlane, et al. (+3)
137 [GO] 2021―Jan―15 COVID-19-associated oxidative damage to red blood cells Muhammad Khakwani, Claire Horgan, Joanne Ewing
138 [GO] 2021―Jan―10 Impact of COVID-19 on red blood cell rheology Céline Renoux, Romain Fort, Elie Nader, Camille Boisson, Philippe Joly, Emeric Stauffer, et al. (+5)
139 [GO] 2021―Jan―06 Are mushroom-shaped erythrocytes an indicator of COVID-19? Delphine Gérard, Safa Ben Brahim, Jean François Lesesve, Julien Perrin
140 [GO] 2021―Jan―02 SARS-CoV-2-induced remission of Hodgkin lymphoma Sarah Challenor, David Tucker
141 [GO] 2020―Dec―25 von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients Maxime Delrue, Virginie Siguret, Marie Neuwirth, Bérangère Joly, Nicolas Beranger, Damien Sène, et al. (+5)
142 [GO] 2020―Dec―18 Secondary haemophagocytic lymphohistiocytosis is a rare occurrence amongst cancer patients with COVID-19 Thomas Hueso, Clémentine Bouchez, Flore Salviat, Stéphanie Foulon, Laurence Albiges, Arnaud Bayle, et al. (+6)
143 [GO] 2020―Dec―18 Von Willebrand factor propeptide in severe coronavirus disease 2019 (COVID-19): evidence of acute and sustained endothelial cell activation Soracha E. Ward, Gerard F. Curley, Michelle Lavin, Helen Fogarty, Ellie Karampini, Natalie L. McEvoy, et al. (+19)
144 [GO] 2020―Dec―18 Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK) Faye A. Sharpley, Jemma Larham, Angus Haines, Faouzi Djebbari, Bing Tseu, Heather Leary, et al. (+9)
145 [GO] 2020―Dec―13 Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies Albrecht Betrains, Laurent Godinas, F. J. Sherida H. Woei-A-Jin, Wouter Rosseels, Yannick Van Herck, Natalie Lorent, et al. (+12)
146 [GO] 2020―Dec―02 COVID-19 associated Kikuchi-Fujimoto disease Laura Stimson, Richard Stitson, Maria Bahhadi-Hardo, Edward Renaudon-Smith
147 [GO] 2020―Nov―25 Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials? Keith Gomez, Mike Laffan, Charlotte Bradbury
148 [GO] 2020―Nov―22 COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial Marquita Camilleri, Jonathan Sive, William Wilson, Gavin Pang, Richard Jenner, Elizabeth Phillips, et al. (+12)
149 [GO] 2020―Nov―22 Telemedicine in patients with haematological diseases during the coronavirus disease 2019 (COVID-19) pandemic: selection criteria and patients’ satisfaction Francesca Palandri, Daniela Bartoletti, Stefania Giaquinta, Federica D’Ambrosio, Giuseppe Auteri, Emanuele Sutto, et al. (+3)
150 [GO] 2020―Nov―20 SARS-CoV-2 persistence and non-protective immunity in infected haematological patients Karolina Akinosoglou, Foteini Paliogianni, Alexandros Spyridonidis, Argiris Symeonidis, Leonidas G. Alexopoulos, Dimitrios Ziazias, et al. (+3)
151 [GO] 2020―Nov―20 SARS-CoV-2 screening for asymptomatic health care workers in UK stem cell transplant units Adrian J. C. Bloor, Fiona L. Dignan, Julia Lee, Kim H. Orchard
152 [GO] 2020―Nov―05 COVID-19 in haematology patients: a multicentre West Midlands clinical outcomes analysis on behalf of the West Midlands Research Consortium Hana Morrissey, Patrick Ball, Anandadeep Mandal, Alan Nevil, Shankara Paneesha, Supratik Basu, et al. (+14)
153 [GO] 2020―Oct―26 Impact of immunosuppression on mortality in critically ill COVID-19 patients Adrien Mirouse, Michaël Darmon, Lara Zafrani, Etienne Lengliné, Elie Azoulay
154 [GO] 2020―Oct―26 Response to ‘Impact of immunosuppression on mortality in critically ill COVID-19 patients’ Thomas A. Fox, Ethan Troy-Barnes, Amy A. Kirkwood, Wei Y. Chan, James W. Day, Selina J. Chavda, et al. (+13)
155 [GO] 2020―Oct―20 Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naïve chronic lymphocytic leukaemia: a case report George Nesr, Rincy Koshy, David Foldes, Huseini Kagdi
156 [GO] 2020―Oct―10 A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID-19) Dominik J. Vogel, Federico Formenti, Andrew J. Retter, Francesco Vasques, Luigi Camporota
157 [GO] 2020―Sep―23 Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection Dina Sheha, Mohamed El-Shayeb, Yara Eid, Mariam Amin, Alia Saeed, Dina Abdou, et al. (+6)
158 [GO] 2020―Sep―18 COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience Alexandra Pike, Petra Muus, Tahla Munir, Lindsay Mitchell, Louise Arnold, Kathryn Riley, et al. (+5)
159 [GO] 2020―Aug―31 Haemoglobin oxygen affinity in patients with severe COVID-19 infection: Still unclear Gurgen Harutyunyan, Garnik Harutyunyan, Gagik Mkhoyan, Varsenik Harutyunyan, Suren Soghomonyan
160 [GO] 2020―Aug―28 COVID-19 and haemoglobin oxygen affinity: some clarity? Michael J. Shattock, Yvonne Daniel, Beverley J. Hunt, Andrew Retter, Katherine Henderson, Sarah Wilson, Claire C. Sharpe
161 [GO] 2020―Aug―07 Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak B de la Cruz-Benito, P Lázaro-del Campo, A Ramírez-López, T de Soto-Álvarez, I Sánchez-Vadillo, E García-Pérez, et al. (+6)
162 [GO] 2020―Aug―03 Abnormal concentration of porphyrins in serum from COVID-19 patients Itxaso San Juan, Chiara Bruzzone, Maider Bizkarguenaga, Ganeko Bernardo-Seisdedos, Ana Laín, Rubén Gil-Redondo, et al. (+9)
163 [GO] 2020―Aug―02 Alice in Wonderland of blood groups and COVID-19 Hisato Takagi
164 [GO] 2020―Jul―17 Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy TA Fox, E Troy-Barnes, AA Kirkwood, WY Chan, J Day, SJ Chavda, et al. (+13)
165 [GO] 2020―Jul―17 Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients Kyung-Chan Park, Killian Donovan, Stuart Mckechnie, Narayan Ramamurthy, Paul Klenerman, Pawel Swietach
166 [GO] 2020―Jul―17 Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients Silvia Bellesi, Elisabetta Metafuni, Stefan Hohaus, Elena Maiolo, Federica Marchionni, Simone D’Innocenzo, et al. (+11)
167 [GO] 2020―Jul―17 Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea John Hoon Rim, Sang Ah Lee, Chang Hoon Han, Jongha Yoo
168 [GO] 2020―Jul―17 Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series Matthieu Mahévas, Guillaume Moulis, Emmanuel Andres, Etienne Riviere, Margaux Garzaro, Etienne Crickx, et al. (+13)
169 [GO] 2020―Jul―11 Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases Abena Appiah-Kubi, Suchitra Acharya, Carolyn Fein Levy, Adrianna Vlachos, Gholamabbas Ostovar, Kristina Murphy, et al. (+5)
170 [GO] 2020―Jul―11 Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study Paul J. Hengeveld, Aaram Omar Khader, Linda H.A. de Bruin, Inge G.P. Geelen, Eske A. van Baalen, Eva Jansen, et al. (+6)
171 [GO] 2020―Jul―11 Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection Katharine Orf, Srdan Rogosic, Daniel Dexter, Phil Ancliff, Saket Badle, Joe Brierley, et al. (+14)
172 [GO] 2020―Jul―09 COVID-19 comorbidities, associated pro-coagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity? Jameel Inal
173 [GO] 2020―Jul―09 Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2 Lúcia Silla
174 [GO] 2020―Jul―08 Blood Component Use in Critical Care in Patients with COVID-19 Infection: A Single Centre Experience Andrew J Doyle, Anicee Danaee, Charlene I Furtado, Scott Miller, Tim Maggs, Susan E Robinson, Andrew Retter
175 [GO] 2020―Jul―08 CoVID-19 insights from transfusion medicine Willy A. Flegel
176 [GO] 2020―Jul―06 Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID-19 critical patients Antonio Chistolini, Franco Ruberto, Francesco Alessandri, Cristina Santoro, Francesco Barone, Maria Cristina Puzzolo, et al. (+66)
177 [GO] 2020―Jul―04 COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges Alfonso Piciocchi, Monica Messina, Stefano Soddu, Edoardo La Sala, Francesca Paoloni, Giorgia Giuliani, et al. (+5)
178 [GO] 2020―Jul―04 Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications Anastasios Kollias, Konstantinos G Kyriakoulis, George S Stergiou, Konstantinos Syrigos
179 [GO] 2020―Jul―01 ABO Phenotype and Death in Critically Ill Patients with COVID-19 Rebecca Karp Leaf, Hanny Al-Samkari, Samantha K. Brenner, Shruti Gupta, David E. Leaf
180 [GO] 2020―Jul―01 Concerns about how to use established minimal residual disease (MRD) monitoring in the treatment of NPM1 -mutant AML following reduced intensity chemotherapy protocols for AML given as a result of the COVID-19 pandemic Nadine Farah, Richard Burt, Amr R Ibrahim, Robert Baker, Panagiotis D Kottaridis
181 [GO] 2020―Jun―27 Convalescent plasma for persisting Covid-19 following therapeutic lymphocyte depletion: a report of rapid recovery E. Clark, P. Guilpain, L. Filip, N. Pansu, C. Le Bihan, G. Cartron, et al. (+6)
182 [GO] 2020―Jun―27 Ruxolitinib for tocilizumab-refractory severe COVID-19 infection Andrew J Innes, Lucy B Cook, Sasha Marks, Edward Bataillard, Christina Crossette-Thambiah, Gayathiri Sivasubramaniam, et al. (+2)
183 [GO] 2020―Jun―27 Successful treatment of chronic myelomonocytic leukaemia with hydroxycarbamide in a patient presenting with acute hypoxic respiratory failure due to COVID-19 pneumonia J. Chopra, HJ. Hiew, A. Cumpstey, F. Cagampang, MW. Jenner, A. Dushianthan
184 [GO] 2020―Jun―25 Successful remission induction therapy with gilteritinib in a patient with de novo FLT3 -mutated acute myeloid leukaemia and severe COVID-19 Andrew J. Wilson, Ethan Troy-Barnes, Maryam Subhan, Fiona Clark, Rajeev Gupta, Adele K. Fielding, et al. (+8)
185 [GO] 2020―Jun―25 COVID-19 mortality in patients on anticoagulants and antiplatelet agents Helena Sivaloganathan, Eleni E Ladikou, Timothy Chevassut
186 [GO] 2020―Jun―25 Amelioration of COVID-19 related cytokine storm syndrome: Parallels to chimeric antigen receptor-T cell cytokine release syndrome Ryan L. Hoiland, Sophie Stukas, Jennifer Cooper, Sonny Thiara, Luke Y.C. Chen, Catherine M. Biggs, et al. (+6)
187 [GO] 2020―Jun―25 Combined IL-6 and JAK-STAT inhibition therapy in COVID-19 related sHLH, potential game changer Sophie Portsmore, Thien Ngoc Tran Nguyen, Emma Beacham, Pratap Neelakantan
188 [GO] 2020―Jun―19 Haematological Cancers and the risk of severe COVID-19: Exploration and critical evaluation of the evidence to date Dima El-Sharkawi, Sunil Iyengar
189 [GO] 2020―Jun―17 Thrombocytopenia is independently associated with poor outcome in patients hospitalized for COVID-19 Julien Maquet, Margaux Lafaurie, Agnès Sommet, Guillaume Moulis, Muriel Alvarez, Jacques Amar, et al. (+47)
190 [GO] 2020―Jun―15 Rapid screening of COVID-19 patients by White blood cells scattergrams, a study on 381 patients Jennifer Osman, Jérome Lambert, Marie Templé, Floriane Devaux, Rémy Favre, Claire Flaujac, et al. (+12)
191 [GO] 2020―Jun―12 C1-INH and the contact system in COVID-19 Timothy M Thomson, Emily Toscano, Ernesto Casis, Rosanna Paciucci
192 [GO] 2020―Jun―12 Haemophagocytosis in bone marrow aspirates in patients with COVID-19 Agathe Debliquis, Inès Harzallah, Joy Y. Mootien, Antoine Poidevin, Guylaine Labro, Amira Mejri, et al. (+3)
193 [GO] 2020―Jun―11 Secondary HLH is uncommon in severe COVID-19 Henry Wood, John Jones, Kit Hui, Tracey Mare, Tasneem Pirani, James Galloway, et al. (+5)
194 [GO] 2020―Jun―11 Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience Vallari Shah, Thinzar Ko Ko, Mark Zuckerman, Jennifer Vidler, Sobia Sharif, Varun Mehra, et al. (+19)
195 [GO] 2020―Jun―09 ITP flare with mild COVID-19 infection in pregnancy: A case report George Nesr, Catherine Garnett, Chris Bailey, Siamak Arami
196 [GO] 2020―Jun―09 Anti-A Isohemagglutinin titers and SARS-CoV2 neutralization: implications for children and convalescent plasma selection Daniele Focosi
197 [GO] 2020―Jun―04 Terminal complement inhibition dampens the inflammation during COVID-19 Austin G Kulasekararaj, Ioanna Lazana, Joanna Large, Kristina Posadas, Helen Eagleton, John Lord Villajin, et al. (+3)
198 [GO] 2020―Jun―04 Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus Tarryn Lee Carlsson, Benjamin Walton, Graham Collin
199 [GO] 2020―Jun―02 Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19 Joseph A. Hippensteel, Ellen L. Burnham, Sarah E. Jolley
200 [GO] 2020―Jun―02 Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in β-Thalassemias: The Nationwide Iranian Experience Mehran Karimi, Sezaneh Haghpanah, Azita Azarkeivan, Zohreh Zahedi, Tahereh Zarei, Maryam Akhavan Tavakoli, et al. (+3)
201 [GO] 2020―Jun―02 Re The source of elevated plasma D-dimer levels in COVID-19 infection Beverley J Hunt, Marcel Levi
202 [GO] 2020―Jun―01 A Case Series of MGUS and COVID-19 Jesus D. Gonzalez-Lugo, Lizamarie Bachier-Rodriguez, Mendel Goldfinger, Aditi Shastri, R. Alejandro Sica, Kira Gritsman, et al. (+7)
203 [GO] 2020―Jun―01 Interleukin-6 Blockade Treatment for COVID-19 associated Cytokine Release Syndrome in a Patient with Poorly Controlled Chronic Myeloid Leukaemia Amita Ranger, Ruby Haji, Richard Kaczmarski, Akila Danga
204 [GO] 2020―Jun―01 Challenges in the Management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic Efstathios Kastritis, Ashutosh Wechalekar, Stefan Schönland, Vaishali Sanchorawala, Giampaolo Merlini, Giovanni Palladini, et al. (+8)
205 [GO] 2020―Jun―01 Harnessing HLA-E-restricted CD8 T lymphocytes for adoptive cell therapy of severe COVID-19 patients Nadia Caccamo, Lucy C. Sullivan, Andrew G. Brooks, Francesco Dieli
206 [GO] 2020―Jun―01 Conquest of COVID-19. Publish it to Death? Robert Peter Gale
207 [GO] 2020―Jun―01 Persisting SARS-CoV-2 viremia after rituximab therapy: Two cases with fatal outcome and a review of literature Phil-Robin Tepasse, Wali Hafezi, Mathias Lutz, Joachim Kühn, Christian Wilms, Rainer Wiewrodt, et al. (+4)
208 [GO] 2020―May―29 Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience Alexandros Kanellopoulos, Maria Zahid Ahmed, Bhuvan Kishore, Richard Lovell, Claire Horgan, Paneesha Shankara, et al. (+12)
209 [GO] 2020―May―27 Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19) Emily Zagorski, Tushar Pawar, Shoja Rahimian, Daniel Forman
210 [GO] 2020―May―26 Delayed-phase thrombocytopenia in patients with coronavirus disease 2019 (COVID-19) Wanxin Chen, Ziping Li, Bohan Yang, Ping Wang, Qiong Zhou, Zhiguo Zhang, et al. (+4)
211 [GO] 2020―May―26 COVID-19 and ABO blood group: another viewpoint Christiane Gérard, Gianni Maggipinto, Jean-Marc Minon
212 [GO] 2020―May―26 Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection Y Daniel, BJ Hunt, A Retter, K Henderson, S Wilson, CC Sharpe, MJ Shattock
213 [GO] 2020―May―26 Efficacy of therapeutic plasma exchange in severe COVID-19 patients Li Zhang, Hui Zhai, Shasha Ma, Jiasheng Chen, Yu Gao
214 [GO] 2020―May―26 Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Francesca Angileri, Sébastien Légaré, Antonella Marino Gammazza, Everly Conway de Macario, Alberto J. L. Macario, Francesco Cappello
215 [GO] 2020―May―26 Clinical significance of blue-green neutrophil and monocyte cytoplasmic inclusions in SARS-CoV-2 positive critically ill patients Miguel D. Cantu, William S. Towne, Foxwell N. Emmons, Maria Mostyka, Alain Borczuk, Steven P. Salvatore, et al. (+4)
216 [GO] 2020―May―23 Managing Sickle Cell Patients With COVID-19 Infection: The Need to Pool Our Collective Experience Kamal Kant Sahu, Ahmad Daniyal Siddiqui, Jan Cerny
217 [GO] 2020―May―21 Molecular mechanisms for thrombosis risk in black people: a role in excess mortality from Covid-19 Roshan amasamy, Kate M Milne, Simon M Stoneham, Timothy JT Chevassut
218 [GO] 2020―May―21 Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with Multiple Myeloma receiving systemic anti-cancer therapy. Gordon Cook, A John Ashcroft, Guy Pratt, Rakesh Popat, Karthik Ramasamy, Martin Kaiser, et al. (+10)
219 [GO] 2020―May―21 IL-1 blockade with anakinra in acute leukaemia patients with severe COVID-19 pneumonia appears safe and may result in clinical improvement James W. Day, Thomas A. Fox, Richard Halsey, Ben Carpenter, Panagiotis D. Kottaridis
220 [GO] 2020―May―20 Protective Role of BTK Inhibitors in Patients with Chronic Lymphocytic Leukemia and COVID-19 Santiago Thibaud, Douglas Tremblay, Sheena Bhalla, Brittney Zimmerman, Keith Sigel, Janice Gabrilove
221 [GO] 2020―May―20 High Fluorescent Lymphocytes Are Increased in COVID-19 Patients Zhao Wang, Yu He, Huaqing Shu, Ping Wang, Hui Xing, Xiaoqian Zeng, Zhaoming Tang
222 [GO] 2020―May―19 Covid-19 and Myeloma: what are the implications for now and in the future? Ciara L Freeman, Joseph Mikhael
223 [GO] 2020―May―19 Acute promyelocytic leukaemia lying under the mask of COVID-19-a diagnostic and therapeutic conundrum Isabel Farmer, Jumoke Okikiolu, Matthew Steel, Chandima Wanniarachchi, Shona Littlewood, Sunil Gupta, et al. (+5)
224 [GO] 2020―May―18 Atypical lymphocytes in peripheral blood of patients with COVID-19 Samuel E. Weinberg, Amir Behdad, Peng Ji
225 [GO] 2020―May―18 Evans syndrome in a patient with COVID-19 Monica Li, Charles B. Nguyen, Zachary Yeung, Katherine Sanchez, Daniel Rosen, Sita Bushan
226 [GO] 2020―May―18 The association between severe COVID-19 and low platelet count: evidence from 31 observational studies involving 7613 participants Shi-Qin Jiang, Qiu-Fen Huang, Wei-Ming Xie, Chao Lv, Xiao-Qing Quan
227 [GO] 2020―May―18 Patients with Sickle cell disease and suspected COVID-19 in a pediatric ICU C Heilbronner, L Berteloot, P Tremolieres, L Dupic, L De Saint Blanquat, F Lesage, et al. (+9)
228 [GO] 2020―May―18 Temporal Changes in Immune Blood Cell Parameters in COVID-19 Infection and Recovery from Severe Infection Christina YC Yip, Eng Soo Yap, Sanjay De Mel, Winnie Z.Y. Teo, Chun-Tsu Lee, Sheryl Kan, et al. (+4)
229 [GO] 2020―May―18 First Covid-19 maternal mortality in the UK associated with thrombotic complications Irshad Ahmed, Ahamed Azhar, Nashwa Eltaweel, Bee K Tan
230 [GO] 2020―May―18 Dynamic relationship between D-dimer and COVID-19 severity Yong Li, Kun Zhao, Hongcheng Wei, Wensen Chen, Wei Wang, Ling Jia, et al. (+6)
231 [GO] 2020―May―18 Successful prevention and screening strategies for COVID-19: focused on patients with hematologic diseases Sung-Yeon Cho, Sung-Soo Park, Ji-Young Lee, Hee-Je Kim, Yoo-Jin Kim, Chang-Ki Min, et al. (+3)
232 [GO] 2020―May―18 Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients James A. Aries, Jeffrey K. Davies, Rebecca L. Auer, Simon L. Hallam, Silvia Montoto, Matthew Smith, et al. (+14)
233 [GO] 2020―May―18 More on “Association between ABO blood groups and risk of SARS-CoV-2 Pneumonia” Jamie M. O’Sullivan, Soracha Ward, Helen Fogarty, James S. O’Donnell
234 [GO] 2020―May―13 More on COVID-19 Coagulopathy in Caucasian patients Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, et al. (+9)
235 [GO] 2020―May―07 Survival study of hospitalized patients with concurrent Covid-19 and haematological malignancies Fernando Martín-Moro, Juan Marquet, Miguel Piris, Berta M Michael, Adolfo J Sáez, Magdalena Corona, et al. (+8)
236 [GO] 2020―May―07 COVID-19 in a patient with pre-existing acute lymphoblastic leukemia Yinlian Wu, Heng Lin, Qiang Xie, Qun Chen, Yanfang Huang, Yueyong Zhu, Lizhou Chen
237 [GO] 2020―May―07 Outcome of a patient with refractory Hodgkin’s Lymphoma on pembrolizumab, infected with SARS-CoV-2 Brendan O’Kelly, Padraig McGettrick, Daniel Angelov, Michael P Fay, Tara McGinty, Aoife G Cotter, et al. (+2)
238 [GO] 2020―May―07 Association between ABO blood groups and risk of SARS-CoV-2 pneumonia Juyi Li, Xiufang Wang, Jian Chen, Yi Cai, Aiping Deng, Ming Yang
239 [GO] 2020―May―06 Arterial thromboembolic complications in COVID-19 in low risk patients despite prophylaxis Daniel O. Griffin, Alexandra Jensen, Mushmoom Khan, Jessica Chin, Kelly Chin, Ryan Parnell, et al. (+2)
240 [GO] 2020―May―06 Autoimmune hemolytic anemia associated with Covid-19 infection Gregory Lazarian, Anne Quinquenel, Mathieu Bellal, Justine Siavellis, Caroline Jacquy, Daniel Re, et al. (+6)
241 [GO] 2020―May―06 Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic S. Pavord, J. Thachil, B. Hunt, M. Murphy, G. Lowe, M. Laffan, et al. (+5)
242 [GO] 2020―May―05 Concomitant hemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID-19 and acute promyelocytic leukemia Mathieu Baldacini, Raoul Pop, Laurent Sattler, Laurent Mauvieux, Karin Bilger, Justine Gantzer, et al. (+4)
243 [GO] 2020―May―05 Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia Chris Lopez, Jeremy Kim, Apurva Pandey, Ted Huang, Thomas G. DeLoughery
244 [GO] 2020―May―05 IL-6 blockade treatment for severe COVID-19 in two patients with multiple myeloma Aristeidis Chaidos, Alexia Katsarou, Chira Mustafa, Dragana Milojkovic, Anastasios Karadimitris
245 [GO] 2020―May―05 COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience Kayleigh A. McCloskey, John Meenan, Rhys Hall, Dimitris A. Tsitsikas
246 [GO] 2020―May―05 Severe COVID-19 infection and thrombotic microangiopathy: success doesn't come easily Eleni Gavriilaki, Robert Alan Brodsky
247 [GO] 2020―May―05 Assessing the Impact of Lockdown: Fresh Challenges for the Care of Haematology Patients in the COVID-19 Pandemic John Willan, Andrew John King, Faouzi Djebbari, Gareth D.H. Turner, Daniel J. Royston, Sue Pavord, et al. (+2)
248 [GO] 2020―May―05 Ph+ Acute Lymphoblastic Leukaemia in Italy During the Covid-19 Pandemic. A Campus ALL Study Robin Foà, Massimiliano Bonifacio, Sabina Chiaretti, Antonio Curti, Anna Candoni, Carmen Fava, et al. (+3)
249 [GO] 2020―May―05 Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease - has not received enough attention till date Brian Hanley, Candice A Roufosse, Michael Osborn, Kikkeri N Naresh
250 [GO] 2020―May―05 Thrombocytopenia as an initial manifestation of Covid-19; Case Series and Literature review Maria Zahid Ahmed, Muhammad Khakwani, Indrani Venkatadasari, Claire Horgan, Hannah Giles, Shailesh Jobanputra, et al. (+4)
251 [GO] 2020―May―05 Favourable outcome of Coronavirus-19 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression Elena Sieni, Francesco Pegoraro, Tommaso Casini, Annalisa Tondo, Barbara Bortone, Maria Moriondo, et al. (+3)
252 [GO] 2020―May―05 SARS-CoV-2 infection anxieties and general population restrictions delay diagnosis and treatment of acute haematological malignancies Matteo Molica, Carla Mazzone, Iole Cordone, Alessia Pasquale, Pasquale Niscola, Paolo de Fabritiis
253 [GO] 2020―Apr―30 Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19 Paul Vulliamy, Sabu Jacob, Ross A Davenport
254 [GO] 2020―Apr―24 COVID-19 Coagulopathy in Caucasian patients Helen Fogarty, Liam Townsend, Cliona Ni Cheallaigh, Colm Bergin, Ignacio Martin-Loeches, Paul Browne, et al. (+9)
255 [GO] 2020―Apr―24 Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic Noémi BA Roy, Paul Telfer, Perla Eleftheriou, Josu de la Fuente, Emma Drasar, Farrukh Shah, et al. (+11)
256 [GO] 2020―Apr―21 COVID-19 Infection in Patients with Sickle Cell Disease Faiz A. Hussain, Franklin U. Njoku, Santosh L. Saraf, Robert E. Molokie, Victor R. Gordeuk, Jin Han
257 [GO] 2020―Apr―20 SARS-CoV-2: A new aetiology for atypical lymphocytes Delphine Gérard, Sylvain Henry, Benoît Thomas
258 [GO] 2020―Apr―18 Changes in Blood Coagulation in Patients with Severe Coronavirus Disease 2019 (COVID-19): a Meta-Analysis Mi Xiong, Xue Liang, You-Dong Wei
259 [GO] 2020―Apr―18 Thromboembolic risk and anticoagulant therapy in COVID-19 patients: Emerging evidence and call for action Anastasios Kollias, Konstantinos G Kyriakoulis, Evangelos Dimakakos, Garyphallia Poulakou, George S. Stergiou, Konstantinos Syrigos
260 [GO] 2020―Apr―16 Reactive lymphocytes in patients with Covid-19 Vanessa Cui Lian Chong, Eric Kian Guan Lim, Eugene Bingwen Fan, Stephrene Seok Wei Chan, Kiat Hoe Ong, Ponnudurai Kuperan
261 [GO] 2020―Apr―16 How we deal with the COVID-19 epidemic in an Italian pediatric onco-hematology clinic located in a region at high density of cases Laura Sainati, Alessandra Biffi
262 [GO] 2020―Apr―16 Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (COVID-19) infected patients Suxin Wan, Qingjie Yi, Shibing Fan, Jinglong Lv, Xianxiang Zhang, Lian Guo, et al. (+9)
263 [GO] 2020―Apr―16 Management of COVID-19 Related Paediatric Blood Samples in a Clinical Haematology Laboratory Joyce Ching Mei Lam, Grace Benjamin Moshi, Soh Hong Ang, Hui Ming Chew, Qing Hui Ng, Andrew Madjukie, Logeswary M
264 [GO] 2020―Apr―14 The proportion of patients with thrombocytopenia in three human-susceptible coronavirus infections: a systematic review and meta-analysis Meng Zhou, Jiaqian Qi, Xueqian Li, Ziyan Zhang, Yifang Yao, Depei Wu, Yue Han
265 [GO] 2020―Apr―13 Editorial - COVID-19 John Barret
266 [GO] 2020―Mar―17 How do we plan hematopoietic cell transplant and cellular therapy with the looming COVID-19 threat? Bhagirathbhai Dholaria, Bipin N. Savani
267 [GO] 2020―Mar―16 Care of haematology patients in a COVID-19 epidemic John Willan, Andrew J. King, Sandy Hayes, Graham P. Collins, Andrew Peniket
 [1] 

267 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.009 sec